| Index | NDX, S&P 500 | P/E | 68.91 | EPS (ttm) | 2.37 | Insider Own | 0.06% | Shs Outstand | 316.95M | Perf Week | -2.84% |
| Market Cap | 51.76B | Forward P/E | 18.66 | EPS next Y | 8.75 | Insider Trans | 3.34% | Shs Float | 316.86M | Perf Month | 3.06% |
| Enterprise Value | 51.78B | PEG | 5.61 | EPS next Q | - | Inst Own | - | Short Float | 2.72% | Perf Quarter | -22.54% |
| Income | 750.00M | P/S | 5.83 | EPS this Y | - | Inst Trans | - | Short Ratio | 2.15 | Perf Half Y | - |
| Sales | 8.87B | P/B | 6.09 | EPS next Y | 12.61% | ROA | 3.87% | Short Interest | 8.61M | Perf YTD | -40.40% |
| Book/sh | 26.81 | P/C | - | EPS next 5Y | 12.29% | ROE | -16.21% | 52W High | 279.98 -41.67% | Perf Year | - |
| Cash/sh | 0.67 | P/FCF | - | EPS past 3/5Y | - | ROIC | 8.06% | 52W Low | 149.20 9.46% | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 31.20 | Sales past 3/5Y | - | Gross Margin | 36.18% | Volatility | 4.15% 3.32% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 5.84 | EPS Y/Y TTM | -73.34% | Oper. Margin | 15.70% | ATR (14) | 6.11 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.83 | Sales Y/Y TTM | -42.54% | Profit Margin | 8.45% | RSI (14) | 53.42 | Recom | 2.50 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.53 | EPS Q/Q | - | SMA20 | 3.23% | Beta | 1.45 | Target Price | 207.92 |
| Payout | 0.00% | Debt/Eq | 0.03 | Sales Q/Q | - | SMA50 | 2.11% | Rel Volume | 0.89 | Prev Close | 163.02 |
| Employees | 30,000 | LT Debt/Eq | 0.03 | Earnings | Oct 28 | SMA200 | -10.04% | Avg Volume | 3.78M | Price | 163.31 |
| IPO Date | Jun 22, 2026 | Option/Short | No / Yes | EPS/Sales Surpr. | -11.76% -1.89% | Net Debt/EBITDA | 8.93 | Volume | 3,360,026 | Change | 0.18% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-15-26 | Reiterated | RBC Capital | Outperform | $250 → $210 |
| Oct-09-26 | Reiterated | Argus Research | $275 → $210 | |
| Oct-07-26 | Reiterated | Goldman Sachs | $190 | |
| Sep-14-26 | Reiterated | Melius Research | $190 | |
| Aug-19-26 | Upgrade | Morgan Stanley | Equal Weight → Overweight | |
| Aug-10-26 | Reiterated | Wells Fargo | $250 → $195 | |
| Aug-10-26 | Reiterated | BMO Capital | Outperform | $276 → $209 |
| Aug-09-26 | Reiterated | Jefferies | $235 → $175 | |
| Aug-07-26 | Reiterated | Morgan Stanley | $235 → $205 | |
| Aug-06-26 | Reiterated | UBS | Neutral | $231 → $213 |
Honeywell Aerospace, Inc. engages in the provision of aerospace and defense critical systems and technologies. It operates through the following segments: Electronic Solutions, Engines & Power Systems, and Control Systems. The Electronic Solutions segment supplies aerospace electronic systems and technologies such as avionics and navigation sensors and electromagnetic defensive solutions. The Engine & Power Systems segment manufactures propulsion systems, APUs, and electric power solutions. The Control Systems segment handles the supply of thermal and motion control systems that enable flight, life support, and safety for the aircraft. The company was founded in 1914 and is headquartered in Phoenix, AZ.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | |
|---|---|---|---|---|---|
| Total Revenue | 8,874 | 17,404 | 15,445 | — | |
| Cost of Goods Sold Incl. D&A | 5,663 | 11,341 | 9,943 | — | |
| Gross Profit | 3,211 | 6,063 | 5,502 | — | |
| Selling, General and Administrative Excl. Other | 1,350 | 2,129 | 1,426 | — | |
| Research and Development | 370 | 677 | 567 | — | |
| Other Operating Expense | 98 | 0 | 0 | — | |
| Operating Income | 1,393 | 3,257 | 3,509 | — | |
| Interest Expense | 403 | 818 | 0 | — | |
| Unusual Expense | — | — | — | — | |
| Non-Operating Income (Expense) | 34 | -83 | -141 | — | |
| Net Income Before Taxes | 1,024 | 2,356 | 3,368 | — | |
| Income Taxes | 256 | 541 | 519 | — | |
| Consolidated Net Income | 750 | 1,780 | 2,817 | — | |
| Net Income From Continuing Operations | 768 | 1,815 | 2,849 | — | |
| Net Income | 750 | 1,780 | 2,817 | — | |
| EPS (Recurring) | 2.37 | 5.62 | 8.89 | — | |
| EPS (Basic, Before Extraordinaries) | 2.37 | 5.62 | 8.89 | — | |
| EPS (Diluted) | 2.37 | 5.62 | 8.89 | — | |
| EBITDA | 1,660 | 3,586 | 3,855 | — | |
| Other After Tax Adjustments | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | |
| Price To Earnings Ratio | 68.91 | — | — | — | |
| Price To Sales Ratio | 5.83 | — | — | — | |
| Gross Margin | 36.18 | 34.84 | 35.62 | — | |
| Operating Margin | 15.70 | 18.71 | 22.72 | — | |
| Net Margin | 8.45 | 10.23 | 18.24 | — | |
| Shares Outstanding | 317 | 317 | 317 | — | |
| Market Capitalization | 51,769 | — | — | — | |
| Operating Lease Expense | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| ARNOLD CRAIG | Director | Sep 01 '26 | Buy | 156.00 | 6,400 | 998,400 | 6,400 | Sep 03 |
| Arlak Karen Elizabeth | SVP and CHRO | Aug 01 '26 | Option Exercise | 0.00 | 582 | 0 | 5,045 | Aug 04 |
| Currier James E | President and CEO | Aug 01 '26 | Option Exercise | 0.00 | 1,551 | 0 | 6,201 | Aug 04 |
| Currier James E | President and CEO | Jul 30 '26 | Option Exercise | 0.00 | 843 | 0 | 4,995 | Aug 03 |
| Arlak Karen Elizabeth | SVP and CHRO | Jul 30 '26 | Option Exercise | 0.00 | 843 | 0 | 4,735 | Aug 03 |
| Arlak Karen Elizabeth | SVP and CHRO | Jul 16 '26 | Option Exercise | 0.00 | 1,757 | 0 | 4,363 | Jul 20 |
| Currier James E | President and CEO | Jul 16 '26 | Option Exercise | 0.00 | 3,253 | 0 | 5,514 | Jul 20 |